Skip to main content

Find Clinical Trials

Home
Conditions
Pathologic Stage III Gastroesophageal Junction Adenocarcinoma

Clinical trial condition

Pathologic Stage III Gastroesophageal Junction Adenocarcinoma

Explore clinical trials studying Pathologic Stage III Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Pathologic Stage III Gastroesophageal Junction Adenocarcinoma trial results

Recruiting

Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer

NCT04511039

Conditions: Advanced Malignant Solid Neoplasm, Clinical Stage III Gastroesophageal Junction Adenocarcinoma, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma, +37 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details